<DOC>
	<DOCNO>NCT01042782</DOCNO>
	<brief_summary>Patients advance gastric cancer treat combination RAD001 ( everolimus ) Mitomycin C .</brief_summary>
	<brief_title>Phase I Study Daily RAD001 Combination With Mitomycin C Patients With Advanced Gastric Cancer Cancer Esophagogastric Junction</brief_title>
	<detailed_description>The purpose monocenter , single-arm , phase I trial determine maximum-tolerated-dose , dose-limiting toxicity ( DLT ) preliminary efficacy safety RAD001 combination Mitomycin C patient advance gastric cancer .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 prior platin contain chemotherapy palliativ set progressive disease adjuvant neoadjuvant therapy within 6 month treatment start date . Histological evidence advance metastatic gastric cancer cancer esophageal junction . At baseline CT MRI scan must demonstrate measurable disease RECIST criterion , i.e. , presence least one measurable lesion . Measurable disease lesion must accurately measure least one dimension long diameter &gt; 20 mm use conventional technique &gt; 10 mm spiral CT scan ( minimum lesion size less double slice thickness ) . At least one measurable lesion outside field prior radiation therapy ( accord RECIST criterion ) . Prior radiotherapy single index lesion allow . Adult male female patient ( â‰¥18 year age ) . Patients must disease amenable surgery , radiation , combine modality therapy curative intent . ECOG 0 1 Life expectance &gt; 4 month Adequate bone marrow function , renal function , liver function Women use acceptable form contraception prior receive RAD001 woman meet protocol definition postmenopausal : 12 month natural ( spontaneous ) amenorrhea 6 month spontaneous amenorrhea serum FSH level &gt; 40 mIU/m 6 week post surgical bilateral oophorectomy without hysterectomy . Fully recover previous surgery , prior chemotherapy radiation therapy ( least 4 week since major surgery prior myelosuppressive chemotherapy ) . With exception alopecia , patient must resolution acute toxic effect prior surgery , radiotherapy , chemotherapy NCI CTC ( Version 2.0 ) grade &lt; =1 . Patients rapidly progressive tumor ( upon decision investigator ) treat &lt; 4 week since last chemotherapy , fully recover side effect . Signed informed consent Anticancer therapy within 3 week enrollment include chemotherapy , hormonal therapy , immunotherapy , radiotherapy . Patients rapidly progressive tumor ( upon decision investigator ) treat &lt; 4 week since last chemotherapy , fully recover side effect . Prior therapy RAD001 ( everolimus ) rapamycins ( sirolimus , temsirolimus ) . Patients treat Mitomycin C No neurotoxicity &gt; = grade 2 CTC No gastric intestinal obstruction Patients take drug know inhibit induce isoenzyme CYP3A Patients concurrent major medical condition liable compromise patient 's participation study ( e.g know HIV infection , uncontrolled diabetes , serious cardiac dysrhythmia condition , New York Heart Association classification III IV , congestive cardiac failure , myocardial infarction within 6 month , unstable angina , chronic acute renal liver disease , uncontrolled serious infection include abscess fistula , etc . ) Patients history another malignancy prior study entry , except curatively treat nonmelanotic skin cancer carcinoma insitu cervical cancer unless complete remission evidence disease therapy disease minimum 5 year No symptomatic brain metastasis . Use investigational drug time enrollment , within 30 day 5 halflives enrollment , whichever longer . Female patient pregnant breast feed History hypersensitivity study drug drug similar chemical structure History malignancy organ system , treat untreated , within past 5 year whether evidence local recurrence metastasis , exception localize basal cell carcinoma skin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>RAD001</keyword>
	<keyword>Mitomycin C</keyword>
	<keyword>MTD</keyword>
</DOC>